CRGT (Cortigent Medical) Net earnings per share change in current year
Cortigent, Inc. (CRGT) develops advanced neuroimplants to restore vision and motor functions. The annual growth rate of net income per share reflects the market valuation of the asset, where the value represents the current metric. Growth is supported by the development of brain-computer interfaces and grants, while stability is ensured by a strong team of bioelectronic engineers and compliance experts.
Comprehensive metric breakdowns and analytics for Cortigent Medical (CRGT)
- current quotes and average value forecast:
- business market valuation indicators:
- book value of equity indicators:
- debt burden and liquidity indicators:
Aggregate Debt to Capital Cortigent, Inc.|CRGT - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Cortigent Inc|CRGT - Company Aggregate Debts|Debts to Net Assets Cortigent, Inc.|CRGT - Company Long-Term Debt|Company Short-Term Indebtedness Cortigent|Quick Liquidity Indicator cortigent.com
- company profitability and valuation multiples indicators:
CRGT - Net Income|Company Profit Forecast Cortigent, Inc.|CRGT - P/E Multiple|Projected Price to Earnings Cortigent Medical|CRGT - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation Cortigent|CRGT - Operating profit EBITDA|Net earnings per share for the trailing year Cortigent|CRGT - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months cortigent.com|CRGT - Earnings per share growth in current year|Projected earnings per share growth rate for next year Cortigent, Inc.
- revenue and sales proceeds data:
Fundamental valuation:CRGT - cortigent.com
The annual growth rate of earnings per share measures the dynamics of the business's net yield, allowing for an assessment of capital management efficiency compared to the previous period. By analyzing the current EPS YoY growth rate, an investor separates market volatility from actual financial results, minimizing the risk of buying a "value trap." For Cortigent, Inc. (CRGT), this metric reflects the progress of clinical developments in neuromodulation, which drive the company's value independently of macroeconomic conditions.
Main competitors
Earnings per share growth rate in current year Biogen Idec (BIIB)|NBIX (neurocrine.com) - Earnings growth in current year|Earnings per share growth rate in current year regencellbioscience.com RGC|Net earnings per share growth this year AXSM (Axsome Therapeutics, Inc.)|ACAD (ACADIA Pharma) - Earnings per share increase in current year|Earnings growth in current year XENE (Xenon Pharmaceuticals Inc)|Net earnings per one share growth for the current year VKTX (Viking Pharma)|SUPN: Net earnings per share growth this year|Earnings per share increase in current year CPRX (catalystpharma.com)|DNLI: Earnings growth in current year|HRMY - Expected net earnings per share growth this year|Net earnings per share growth this year BHVN|AMLX: Earnings per share increase in current year|Earnings per share growth in current year Trevi Pharma (TRVI)|Expected net earnings per share growth this year praxismedicines.com|Earnings per share growth in current year Anavex AVXL|Expected net earnings per share growth this year CeriBell (CBLL)|PRTA - Earnings per share growth in current year|ALEC: Earnings per share growth in current year|Annexon (ANNX) - Earnings per share growth in current year|OMER: Net earnings per one share growth for the current year|NGNE (neurogene.com) - Earnings growth in current year|Earnings growth in current year AC Immune S.A.|Net earnings per share growth this year VYGR (Voyager Therapeutics, Inc.)|Net earnings per one share growth for the current year NMRA|Earnings per share growth in current year scilexholding.com SCLX|TVGN: Earnings per share growth this year|alphacognition.com - Earnings growth in current year|Cognition Therapeutics - Net earnings per one share growth for the current year|IKT: Earnings growth in current year|Net earnings per share growth this year Cassava Sciences, Inc.|ASRT (assertiotx.com) - Earnings growth in current year|Net earnings per share growth this year Coya Therapeutics (COYA)|Net earnings per share growth this year VTGN (Vistagen)|Expected net earnings per share growth this year Ovid Therapeutics Inc|Earnings growth in current year ABOS (Acumen Pharmaceuticals Inc.)|CRVO - Net earnings per share growth this year|Alterity Therapeutics Limited - Earnings growth in current year|Earnings per share growth rate in current year Clene Inc|PEPG: Earnings growth in current year|Net earnings per share growth this year jupiterneurosciences.com|RLMD (relmada.com) - Earnings growth in current year|Earnings growth in current year Annovis Bio Corporation|Earnings growth in current year GRCE|AIFF: Earnings per share trend in current year|Earnings per share growth in current year Klotho Neurosciences KLTO|NRSN: Earnings per share growth this year|RVPH: Net earnings per share growth this year|Expected net earnings per share growth this year MetaVia MTVA|neuraxis.com (NRXS) - Earnings per share growth in current year|Helius Medical Technologies Inc. - Earnings per share increase in current year|PASG (Passage Bio, Inc.) - Earnings growth in current year|bionomics.com.au - Earnings per share trend in current year|Earnings growth in current year NERV|ATHA (Athira) - Earnings per share increase in current year|Addex Therapeutics - Net earnings per share growth this year|ALZN - Net earnings per share growth this year|Cyclerion Therapeutics, Inc. - Earnings growth in current year|Earnings per share increase in current year PTIX (Protagenic Therapeutics, Inc.)|KTTA (pasitheaclinics.com) - Net earnings per share growth this year|Avenue Therapeutics - Earnings per share increase in current year|BCLI (brainstorm-cell.com) - Earnings growth in current year|CARA: Earnings per share increase in current year|Earnings per share growth in current year Chromocell Therapeutics Corp (CHRO)|ELYM (Eliem Therapeutics Inc.) - Earnings per share increase in current year|Earnings growth in current year ITCI (Intra-Cellular Therapies Inc.)|Net earnings per share change in current year Longboard Pharma|MRNS - Earnings per share growth in current year|NKGen Biotech, Inc. (NKGN) - Net earnings per share growth this year|NRBO (NeuroBo Pharmaceuticals, Inc.) - Net earnings per share growth this year|Sage Therapeutics - Earnings per share increase in current year|Earnings per share growth in current year Synaptogenix, Inc.|TRVN: Earnings per share increase in current year|Earnings growth in current year VIGL|Net earnings per share growth this year Anew Medical, Inc. WENA|Earnings per share growth in current year Cerevel Therapeutics CERE
